Cortisol is built from cholesterol inside the adrenal glands, assembled through a chain of enzyme-driven reactions that shuttle a simple fat molecule through multiple chemical modifications until it becomes a finished stress hormone. The adrenal cortex, a thin rind of tissue sitting atop each kidney, houses the cellular machinery for this conversion, but the process only runs when signaled by the brain. What makes cortisol synthesis interesting is how many moving parts have to work in sequence, and how the body layers on controls at nearly every step to keep output within a narrow range.
Cholesterol as the Raw Material
Every steroid hormone your body makes, whether it is cortisol, testosterone, estrogen, or aldosterone, starts from the same precursor: cholesterol. The adrenal glands get their cholesterol from two places. Some of it arrives via the bloodstream, carried by lipoproteins (the same particles measured on a standard cholesterol panel). The rest is manufactured locally inside adrenal cells themselves.1Metabolism. Adrenal cortical function in homozygous familial hypercholesterolemia Under normal conditions, lipoprotein uptake is the main supply route, but the adrenal gland can ramp up its own cholesterol production if circulating levels fall short.
Having cholesterol available in the cell is only the first hurdle. The actual enzyme that kicks off cortisol synthesis sits deep inside the mitochondria, on the inner membrane. Cholesterol, though, tends to accumulate on the outer mitochondrial membrane. Getting it across that gap is a bottleneck, and it requires a dedicated shuttle protein.
The StAR Protein and the Rate-Limiting Step
The protein that moves cholesterol from the outer to the inner mitochondrial membrane is called StAR (steroidogenic acute regulatory protein). This transfer is widely considered the rate-limiting step in cortisol production, meaning it controls how fast the whole downstream chain can run. StAR acts exclusively on the outer membrane, ferrying large amounts of cholesterol inward to where the first enzyme is waiting.2PubMed. Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter Without StAR, the enzymes downstream would have almost nothing to work on, and steroid hormone production would stall.3PubMed Central. STAR/STARD1: A mitochondrial intermembrane space cholesterol shuttle degraded through mitophagy
StAR production itself is one of the things that ACTH, the brain’s “make cortisol” signal, stimulates when it reaches the adrenal gland. So the rate-limiting step is also a regulated step, which gives the body tight control over how much cortisol enters production at any given moment.
The First Enzymatic Cut
Once cholesterol reaches the inner mitochondrial membrane, it meets an enzyme called P450scc (also known as CYP11A1), the cholesterol side-chain cleavage enzyme. This enzyme chops off a chunk of the cholesterol molecule’s side chain and converts it into pregnenolone. This is the universal first step for all steroid hormones. Whether the end product will be cortisol, aldosterone, or a sex hormone depends on which enzymes act on pregnenolone next.4PubMed. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency P450scc is the only enzyme capable of performing this conversion, which is why defects in it are devastating: they block production of every steroid the body makes.5PubMed Central. Cholesterol Side-Chain Cleavage Enzyme (SCC) Deficiency
Pregnenolone then leaves the mitochondria and enters the smooth endoplasmic reticulum, a different compartment inside the cell, where the next set of enzymes takes over. For cortisol specifically, pregnenolone is first converted to 17-hydroxypregnenolone by an enzyme called CYP17 (17α-hydroxylase), and then to 17-hydroxyprogesterone. Another enzyme, CYP21A2 (21-hydroxylase), adds a hydroxyl group to produce 11-deoxycortisol. This intermediate then has to travel back into the mitochondria for the final step.
The Final Hydroxylation
The last reaction in cortisol synthesis takes place back in the mitochondria, where the enzyme CYP11B1 (11β-hydroxylase) converts 11-deoxycortisol into cortisol. This single hydroxylation is what turns a biologically inactive precursor into a fully active glucocorticoid.6PubMed. Efficient conversion of 11-deoxycortisol to cortisol (hydrocortisone) by recombinant fission yeast Schizosaccharomyces pombe CYP11B1 sits in the same mitochondrial neighborhood as a closely related enzyme, CYP11B2 (aldosterone synthase), which handles the final steps in aldosterone production. The two enzymes share about 93% of their genetic sequence, yet they have distinct jobs and are expressed in different zones of the adrenal cortex.7PubMed. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol
The fact that the pathway bounces back and forth between the mitochondria and the endoplasmic reticulum is unusual. Most metabolic pathways stay within one cellular compartment. This shuttling means cortisol synthesis depends not only on having the right enzymes but also on intact intracellular transport machinery.
Where in the Adrenal Gland Cortisol Is Made
The adrenal cortex is not a uniform slab of tissue. It has three concentric layers, each specializing in different hormones. The outermost zone, the zona glomerulosa, produces aldosterone (a mineralocorticoid that regulates sodium and potassium). The middle zone, the zona fasciculata, is where cortisol is made. The innermost zone, the zona reticularis, produces androgens like DHEA.8PubMed Central. Transcriptome analysis reveals differentially expressed transcripts in rat adrenal zona glomerulosa and zona fasciculata
This layered arrangement appears to be maintained in part by the way blood flows through the gland. Blood moves inward from the outer capsule toward the center (the medulla), creating a gradient of glucocorticoids that gets stronger as cells sit deeper. Research suggests this glucocorticoid gradient itself acts as a signal that helps cells “know” which zone they belong to and which enzymes to express.9PubMed. Control of CYP11B2/CYP11B1 expression ratio and consequences for the zonation of the adrenal cortex The zona fasciculata, as the thickest of the three zones, accounts for the bulk of the adrenal cortex’s mass, reflecting just how much cortisol production the body prioritizes.
The boundaries between zones are not rigid walls, though. Some intermediate compounds like corticosterone and deoxycorticosterone, which are typically associated with mineralocorticoid pathways, are also produced in the zona fasciculata under the control of ACTH.10PubMed Central. Classic and current concepts in adrenal steroidogenesis: a reappraisal The zonal model is useful, but the reality is somewhat messier.
What Tells the Adrenal Gland to Make Cortisol
Cortisol synthesis does not run constantly at the same rate. It is driven by a signaling cascade that starts in the brain. When you encounter stress, whether physical or psychological, the hypothalamus releases corticotropin-releasing hormone (CRH), which tells the pituitary gland to release ACTH into the bloodstream. ACTH travels to the adrenal cortex and binds to a receptor called MC2R on the surface of zona fasciculata cells. That binding triggers a chain of intracellular events: a rise in cyclic AMP, activation of protein kinase A, and ultimately the production of StAR, which as described earlier pushes cholesterol into the mitochondria to start the enzymatic cascade.11Endocrine Reviews. Dynamics of ACTH and Cortisol Secretion and Implications for Disease
The MC2R receptor has an interesting quirk: it cannot bind ACTH on its own. It needs a helper molecule called MRAP (melanocortin-2 receptor accessory protein). Without MRAP, ACTH simply fails to dock with the receptor, and no signal gets through.12PubMed. Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells Different forms of MRAP appear to fine-tune this signaling: one isoform helps get MC2R to the cell surface, while another enhances the strength of the downstream signal once ACTH binds.13PubMed. The C-terminal domains of melanocortin-2 receptor (MC2R) accessory proteins (MRAP1) influence their localization and ACTH-induced cAMP production This dependency on an accessory protein adds yet another layer of regulation to cortisol output.
The Feedback Loop That Keeps Cortisol in Check
Once cortisol enters the bloodstream, it feeds back to both the hypothalamus and the pituitary to suppress further CRH and ACTH release. This negative feedback loop is what prevents cortisol from spiraling upward indefinitely after a stressful event. The speed of this feedback is striking: cortisol can reduce ACTH secretion within minutes by altering the electrical activity of pituitary corticotroph cells. It dampens both the spontaneous firing of these cells and the bursts of activity triggered by CRH, an effect that depends on specific ion channels in the cell membrane.14PubMed Central. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility
There is also a slower form of feedback that works over hours and involves changes in gene expression, reducing the amount of CRH and ACTH that cells produce in the first place. Together, the fast and slow mechanisms create a self-correcting system. When the system works properly, cortisol rises in response to a challenge, then falls back to baseline once the challenge passes.
The Daily Rhythm of Cortisol Production
Cortisol does not simply respond to stress on demand. It follows one of the most pronounced circadian rhythms of any hormone. Levels peak in the early morning hours, typically around the time you wake up, and decline through the day, reaching their lowest point around midnight. This daily cycle is governed by the suprachiasmatic nucleus, the brain’s master clock, which sits in the hypothalamus and keeps hormonal output synchronized with the light-dark cycle.15PubMed Central. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy
The circadian rhythm is not just centrally driven, either. The adrenal gland itself contains molecular clock components that contribute to the daily oscillation of cortisol output. Research has shown that these local adrenal clocks influence glucocorticoid rhythms at multiple levels, from enzyme expression to cholesterol availability.16PubMed. Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications Disruptions to this rhythm, whether from shift work, jet lag, or disease, can throw cortisol patterns out of alignment with the rest of the body’s metabolic timing.
Fine-Tuning at the Tissue Level
Even after cortisol leaves the adrenal gland and enters the bloodstream, its activity is not fixed. Individual tissues have their own control mechanism: a pair of enzymes called 11β-hydroxysteroid dehydrogenases (11β-HSD) that can switch cortisol on or off locally. The type 1 enzyme, 11β-HSD1, converts inactive cortisone back into active cortisol, effectively amplifying the glucocorticoid signal in tissues like the liver, fat, and brain. The type 2 enzyme, 11β-HSD2, does the opposite: it converts cortisol into cortisone, shutting down its activity.17PubMed. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase
This local switching matters because cortisol can bind not only to its own receptor (the glucocorticoid receptor) but also to the mineralocorticoid receptor, the same receptor aldosterone uses. In the kidneys, where aldosterone regulates salt balance, 11β-HSD2 inactivates cortisol to prevent it from hijacking the mineralocorticoid receptor.18PubMed Central. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action Without this gatekeeping, cortisol (which circulates at much higher concentrations than aldosterone) would overwhelm the system, and you would end up retaining sodium and losing potassium as if aldosterone were flooding your body.
The balance between these two enzymes has become a target of medical interest. Overactivity of 11β-HSD1 in fat tissue, for instance, has been linked to features of metabolic syndrome, because it generates excess local cortisol right where it can drive fat accumulation and insulin resistance.19Journal of Endocrinology. 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Cortisol Synthesis Outside the Adrenal Glands
The adrenal glands are overwhelmingly the body’s main cortisol factory, but they are not the only site. Over the past two decades, researchers have found that several other tissues, including the intestinal lining, the skin, the brain, and primary lymphoid organs, can produce small amounts of glucocorticoids locally.20PubMed Central. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function This evidence comes partly from finding steroidogenic enzymes in those tissues, and partly from detecting elevated local glucocorticoid levels even after the adrenal glands have been removed.
The intestinal mucosa has received particular attention. Local glucocorticoid production in the gut appears to help regulate immune responses, keeping the immune system from overreacting to the trillions of bacteria living in the intestine.21PubMed Central. Extra-Adrenal Glucocorticoid Synthesis in the Intestinal Mucosa: Between Immune Homeostasis and Immune Escape The amounts produced are tiny compared to what the adrenal glands put out, but they appear to matter locally. This is still an active area of research, and the exact regulation of these extra-adrenal sources is not fully mapped.
When the Pathway Breaks Down
The most common genetic disorder of cortisol synthesis is congenital adrenal hyperplasia (CAH), a group of conditions caused by defects in the enzymes of the steroidogenic pathway. The most frequent form involves mutations in the gene for 21-hydroxylase (CYP21A2), the enzyme that converts 17-hydroxyprogesterone to 11-deoxycortisol.22PubMed Central. Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of CYP21A2 Gene When 21-hydroxylase does not work properly, the pathway gets stuck: cortisol levels stay low, and the intermediates that would normally flow toward cortisol pile up and get shunted toward androgen production instead.
The feedback loop described earlier makes the problem worse. Because cortisol remains low, the pituitary keeps pumping out ACTH in an attempt to force higher production. This chronic overstimulation causes the adrenal glands to enlarge, which is where the name “hyperplasia” comes from. The excess ACTH also drives the overproduction of androgens, since that branch of the pathway is still intact.23PubMed. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia Treatment typically involves replacing the missing cortisol with synthetic glucocorticoids, which satisfies the feedback loop and brings ACTH back down.
Blocking Cortisol Synthesis on Purpose
In conditions where cortisol is overproduced, such as Cushing’s syndrome, doctors sometimes use drugs that deliberately block one of the enzymes in the synthesis pathway. Osilodrostat is one such drug. It inhibits CYP11B1, the enzyme that performs the final hydroxylation of 11-deoxycortisol to cortisol. By blocking this step, the drug causes cortisol levels to drop sharply while its immediate precursor, 11-deoxycortisol, accumulates.24The Journal of Clinical Endocrinology & Metabolism. Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study Osilodrostat has been approved for treating adults with Cushing’s syndrome, particularly those with Cushing’s disease (the pituitary-driven form) who cannot be cured by surgery.25PubMed Central. Osilodrostat: A Novel Potent Inhibitor of 11-Beta-Hydroxylase for the Treatment of Cushing’s Syndrome
Other drugs target different points in the pathway. Metyrapone, an older medication, also inhibits 11β-hydroxylase but is less selective. Ketoconazole, originally an antifungal, blocks several steroidogenic enzymes at higher doses and has long been used off-label for Cushing’s syndrome. The existence of multiple pharmacological targets along the pathway gives clinicians options depending on which side effects a patient can tolerate and which precursors might build up.
Why Rats and Mice Make a Different Hormone
If you have ever read a stress study done in rodents, you may have noticed that the hormone measured is usually corticosterone, not cortisol. This is not just a naming difference. Rats and mice genuinely do not produce appreciable amounts of cortisol, because they lack 17α-hydroxylase (CYP17) in their adrenal cortex. Without that enzyme, the pathway cannot route pregnenolone through the 17-hydroxy intermediates that lead to cortisol. Instead, it follows the unbranched path to corticosterone, which serves as the primary glucocorticoid in those species.26Endocrinology. CORT, Cort, B, Corticosterone, and now Cortistatin: Enough Already!
Corticosterone binds the same glucocorticoid receptor that cortisol does in humans, so functionally the two hormones overlap. But this species difference is worth knowing about, because it means rodent studies of “stress hormones” are measuring a slightly different molecule than the one circulating in your blood. Most mammals, including primates and dogs, produce cortisol as their dominant glucocorticoid.
How the Fetal Adrenal Gland Handles Things Differently
The human fetal adrenal gland does not operate like the adult version. Early in development, the fetal adrenal briefly produces cortisol, but then cortisol synthesis is actively suppressed for most of gestation. Instead, the fetal adrenal churns out large quantities of DHEA and its sulfated form, which the placenta converts into estrogens needed to maintain the pregnancy.27PubMed Central. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit Cortisol production ramps back up only late in gestation, when it plays a role in maturing the fetal lungs and other organs in preparation for birth.
This temporary suppression of cortisol synthesis makes developmental sense. The fetus relies on maternal cortisol (partially inactivated by placental 11β-HSD2 to prevent excess exposure) and does not need to run its own production line for most of pregnancy. The fetal adrenal gland is disproportionately large relative to body size and actually shrinks after birth once the demand for DHEA drops and adult-pattern steroidogenesis takes over.